Rakuten Medical
Rakuten Medical, Inc.
Rakuten Medical, Inc. is a global biotechnology company developing precision, cell-targeting investigational therapies on its Alluminox™ technology platform which, in pre-clinical studies have been shown to induce rapid and selective cell killing and tumor necrosis.Rakuten Medical is committed to it
rakuten-med.com · San Diego, CA
Funding event
The round itself, as filedInferred stageSeries A
Sold of offered$9.0M of $9.0M
Filed2026-10-06
Days since filing12
- Exemption claimed
- Rule 506(b)
- First-ever Form D
- No
- Date of first sale
- 2026-08-16
Investors
No investors named: Form D does not list them
Officers on the filing
Names and roles as filed; addresses are never stored- Maeda MinamiExecutive Officer
- David ChaoDirector
- Miguel Garcia-GuzmanDirector
- Hiroshi MikitaniDirector
- Hiroshi MoriDirector
- Ken TakeshitaDirector
- Christophe WeberDirector
- Nitin NohriaDirector
- Eiichi KagaDirector
- Mazen DarwazehDirector
- Tiffany PiecewiczExecutive Officer
- Abhijit BhatiaExecutive Officer
- Toshiaki SuzukiExecutive Officer
- Suzane SanExecutive Officer
- Hiroyuki KodamaExecutive Officer
- Louise ChangExecutive Officer
- Amy ThorneExecutive Officer
- Anthony ManibusanExecutive Officer
- Hassan DanesiExecutive Officer
Health flags
Three flags, each with the raw inputs behind it · as of 2026-10-17UndersubscribedNot flagged100% sold2 months since first sale
Prior raiseFlaggedRaised 8% of its prior round, 5 months on$112M prior raise, filed 2026-04-13
AmendedNot flaggedNo amendmentNo D/A on file
Open roles
On the employer's own careers page · checked 2026-10-070
Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.
No open roles foundWe read careers pages daily.
Also raised in Health & bio
Same sector, 28 days to 2026-10-18Estuary BioSeries B · $40.7M of $104M · Menlo Park, CAQuietNorth Elam Ambulatory Surgery Center, LLCSeed · $1.8M of $2.7M · Greensboro, NCQuiet
70 rounds in Health & bio in the 28 days to 2026-10-17, against 66 in the 28 days before.